N. Sugimoto

发表

Xlim-1 and LIM domain binding protein 1 cooperate with various transcription factors in the regulation of the goosecoid promoter.

I. Dawid, T. Watabe, K. Shiokawa, 2000, Developmental biology.

A phase 2 study of capecitabine plus oxaliplatin therapy (XELOX) for patients with inoperable/advanced gastric cancer who were resistant/intolerable to fluoropyrimidine, CDDP, taxane, and CPT-11 (OGSG1403).

D. Sakai, Y. Kurokawa, T. Shimokawa, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Identification of DJ-1-Associated Regions on Human Genes from SH-SY5Y Cells using Chromatin Immunoprecipitation Sequence Technique

K. Takahashi-Niki, H. Ariga, T. Yamane, 2014 .

1513MO A phase II study of nivolumab plus low dose ipilimumab as first -line therapy in patients with advanced gastric or esophago-gastric junction MSI-H tumor: First results of the NO LIMIT study (WJOG13320G/CA209-7W7)

Y. Komatsu, M. Tsuda, N. Sugimoto, 2023, Annals of Oncology.